# Sutro Biopharma, Inc.: Form 8-K, filed May 19, 2021

- Company: [Sutro Biopharma, Inc.](/companies/stro.md) (CIK 1382101)
- Form: 8-K
- Filed: 2021-05-19
- Accepted by EDGAR: May 19, 2021, 17:00 ET
- Period: 2021-05-19
- Accession: 0001564590-21-028892
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1382101/000156459021028892/stro-8k_20210519.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1382101/000156459021028892/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1382101/000156459021028892/stro-8k_20210519.htm

Filed May 19, 2021.
Source: SEC EDGAR, the filing index for accession 0001564590-21-028892. Last ingested by Listed: Oct 24, 2026, 15:12 ET. No prices; not investment advice.